Why is Arcellx stock up 80% today? Gilead’s $7.8B answer
Arcellx stock (NASDAQ: ACLX) climbed roughly 80% in premarket trade on Monday after Gilead Sciences agreed to buy the cancer-therapy developer in a
Arcellx stock (NASDAQ: ACLX) climbed roughly 80% in premarket trade on Monday after Gilead Sciences agreed to buy the cancer-therapy developer in a
South Korea’s stablecoin framework is facing renewed scrutiny as the country’s central bank urges lawmakers to keep control of won-pegged digital tokens within
Finland’s IQM is positioning itself at the centre of Europe’s quantum technology ambitions as it prepares to enter public markets in the US.
Blue Owl stock price has crashed in the past few months, turning one of the most blue-chip financial giants into a fallen angel.
Fridays used to be reserved for routine headlines. But since Donald Trump’s reelection, every Friday seems like a bombshell day. And last Friday
Merck said on Monday that it will split its human-health operations into two separate divisions, a move designed to sharpen focus across its
Royal Bank of Canada stock has been in an unstoppable bull run in the past few years and is now hovering at its
Millions of people on GLP-1 weight-loss drugs know the weekly routine by heart: a new injector pen, a new box, another reminder to
The NZD/USD exchange rate continued its strong rally last week, reaching its highest level since June last year. It has now soared in
The South African rand remains in a bull market as the country’s economic recovery gains steam. The USD/ZAR pair dropped to 15.92 on